Subpopulations (%)

All patients with RMS

Control group

Р

CD3+ HLADR+

35.5 ± 6.0

(n = 15)

12.5 ± 2.0

(n = 12)

0.003

CD8+ HLADR+

28.7 ± 6.1

(n = 10)

8.9 ± 1.4

(n = 11)

0.001

γδTCR Т cells

15.7 ± 1.6

(n = 11)

9.6 ± 1.5

(n = 10)

0.013